低血糖控制增加了斯里兰卡人口的牙风险
Larissa Steigmann1, Sejal Gunaratnam2, William V Giannobile1
1Division of Periodontology, Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, MA 02115, USA.
Healthcare (Basel, Switzerland)
|February 10, 2024
概括
糖尿病患者血糖水平较高,面临明显增加的牙科风险. 低血糖控制与更频繁的牙问题密切相关,影响口腔健康结果.
科学领域:
- 口腔健康 口腔健康
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 糖尿病是一种全球性健康问题,对口腔健康有重大影响.
- 斯里兰卡的特林科马利面临着日益增长的糖尿病负担,需要对其并发症进行研究.
研究的目的:
- 检查2型糖尿病患者糖尿病相关因素与牙科疾病结局之间的关系.
- 在这个人群中确定牙科风险的关键预测因素.
主要方法:
- 在斯里兰卡的Trincomalee评估了80名2型糖尿病患者的队列.
- 记录了牙科结果,并根据观察到问题的频率计算了牙科风险得分.
- 参与者被分为低风险 (≤3个牙科结果) 和高风险 (>3个牙科结果).
主要成果:
- 观察到牙周问题的高患病率,包括70%的牙缺失,40%的牙衰退,41%的牙可移动,20%的牙出血.
- 39%的参与者被归类为牙科风险高,而61%的风险低.
- 升高的毛细血管血糖水平与更高的牙科风险得分 (OR = 2.93) 有显著的关联.
结论:
- 血糖控制不良,由毛细血管血糖升高表明,是糖尿病患者牙问题增加的重要危险因素.
- 经年龄调整的分析证实,高血糖的人群中,高牙风险的几率增加了3倍.
- 这些发现强调了管理血糖水平的重要性,以减轻糖尿病护理中的牙科并发症.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
175
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
175
Diabetes: Symptoms, Diagnosis, and Complications
544
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
544
Oral Hypoglycemic Agents: Glinides
154
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
154
Overview of Carbohydrate Metabolism
1.0K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.0K
Hypoglycemia and Glucagon
263
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
263


